Virbac SA (VIRPPA) DCF Valuation

Valoración de DCF Virbac SA (Virp.PA)

FR | Healthcare | Drug Manufacturers - General | EURONEXT
Virbac SA (VIRPPA) DCF Valuation
  • Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • Predeterminadas Para Un Uso Rápido Y Eficiente
  • No Se Necesita Experiencia; Fáciles De Seguir

Virbac SA (VIRP.PA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Haga cargo de su análisis de valoración de Virbac SA (Virppa) con nuestra calculadora DCF de última generación! Precedidos con datos reales (Virppa), esta plantilla de Excel le permite ajustar los pronósticos y supuestos para calcular con precisión el valor intrínseco de Virbac SA.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 938.3 934.2 1,064.0 1,216.2 1,246.9 1,341.3 1,442.8 1,552.1 1,669.6 1,796.0
Revenue Growth, % 0 -0.44163 13.89 14.31 2.53 7.57 7.57 7.57 7.57 7.57
EBITDA 149.1 231.7 199.5 215.6 230.7 256.6 276.0 296.9 319.4 343.6
EBITDA, % 15.89 24.8 18.75 17.72 18.5 19.13 19.13 19.13 19.13 19.13
Depreciation 54.7 47.6 43.3 45.8 47.5 60.6 65.2 70.1 75.4 81.1
Depreciation, % 5.83 5.1 4.07 3.77 3.81 4.52 4.52 4.52 4.52 4.52
EBIT 94.4 184.0 156.1 169.7 183.1 196.0 210.9 226.8 244.0 262.5
EBIT, % 10.06 19.7 14.67 13.96 14.69 14.61 14.61 14.61 14.61 14.61
Total Cash 94.0 181.9 172.8 177.4 175.9 199.6 214.8 231.0 248.5 267.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 140.8 162.1 165.0 200.6 240.1
Account Receivables, % 15.01 17.35 15.51 16.49 19.26
Inventories 206.6 212.7 274.3 333.8 339.7 336.0 361.4 388.8 418.2 449.9
Inventories, % 22.02 22.77 25.78 27.45 27.24 25.05 25.05 25.05 25.05 25.05
Accounts Payable 90.1 96.5 116.9 142.5 133.2 143.0 153.8 165.5 178.0 191.5
Accounts Payable, % 9.6 10.33 10.99 11.71 10.68 10.66 10.66 10.66 10.66 10.66
Capital Expenditure -16.7 -29.0 -47.2 -53.6 -59.9 -49.7 -53.5 -57.5 -61.9 -66.5
Capital Expenditure, % -1.78 -3.1 -4.43 -4.41 -4.8 -3.71 -3.71 -3.71 -3.71 -3.71
Tax Rate, % 30.35 30.35 30.35 30.35 30.35 30.35 30.35 30.35 30.35 30.35
EBITAT 62.5 144.4 117.7 124.7 127.6 142.4 153.2 164.8 177.2 190.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -156.8 142.2 69.7 47.5 60.5 182.5 133.3 143.4 154.2 165.9
WACC, % 8.67 8.71 8.7 8.69 8.68 8.69 8.69 8.69 8.69 8.69
PV UFCF
SUM PV UFCF 612.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 169
Terminal Value 2,529
Present Terminal Value 1,668
Enterprise Value 2,280
Net Debt -56
Equity Value 2,336
Diluted Shares Outstanding, MM 8
Equity Value Per Share 276.83

What You Will Receive

  • Authentic Virbac Data: Comprehensive financials – from revenue to EBIT – derived from actual and projected data.
  • Complete Customization: Modify all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
  • Instant Valuation Adjustments: Automatic recalculations to evaluate the effects of changes on Virbac's fair value.
  • Flexible Excel Template: Designed for easy edits, scenario analysis, and in-depth forecasts.
  • Efficient and Precise: Bypass the hassle of building models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Virbac SA (VIRPPA).
  • WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet that allows for customizable inputs.
  • Flexible Forecast Assumptions: Easily adjust growth rates, capital expenditures, and discount rates to fit your analysis.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency metrics specific to Virbac SA (VIRPPA).
  • Visualization Dashboards and Charts: Provides visual summaries of essential valuation metrics for straightforward analysis.

How It Operates

  1. Step 1: Download the Excel file for Virbac SA (VIRPPA).
  2. Step 2: Examine the pre-filled financial data and forecasts provided for Virbac SA.
  3. Step 3: Adjust essential inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model refresh in real-time as you modify your assumptions.
  5. Step 5: Evaluate the results and utilize them for your investment strategies.

Why Choose This Calculator for Virbac SA (VIRPPA)?

  • Precision: Based on actual Virbac financial data to ensure reliable results.
  • Adaptability: Tailored for users to easily test and adjust various inputs.
  • Efficiency: Eliminate the complexity of creating a DCF model from the ground up.
  • High-Caliber: Crafted with the accuracy and usability standards expected at the CFO level.
  • Intuitive: Simple interface that allows even beginners to navigate with ease.

Who Should Use This Product?

  • Individual Investors: Make well-informed decisions about trading Virbac SA (VIRPPA) shares.
  • Financial Analysts: Optimize valuation processes using comprehensive financial models tailored for Virbac SA (VIRPPA).
  • Consultants: Provide clients with accurate and timely valuation insights related to Virbac SA (VIRPPA).
  • Business Owners: Gain insights into the valuation methods of established firms like Virbac SA (VIRPPA) to refine your strategic approach.
  • Finance Students: Explore valuation techniques with real-world data and case studies focused on Virbac SA (VIRPPA).

Contents of the Template

  • Historical Data: Features Virbac SA’s previous financial performance and foundational forecasts.
  • DCF and Levered DCF Models: Comprehensive templates for assessing the intrinsic value of Virbac SA (VIRPPA).
  • WACC Sheet: Ready-made calculations for the Weighted Average Cost of Capital.
  • Editable Inputs: Adjust pivotal parameters such as growth rates, EBITDA percentages, and CAPEX assumptions.
  • Quarterly and Annual Statements: An in-depth analysis of Virbac SA’s financial data.
  • Interactive Dashboard: Dynamically visualize valuation outcomes and forecasts.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.